Open AccessAllergic bronchopulmonar aspergillosis in asthmatic patients
Author(s) -
Y I Kozlova,
Я И Козлова,
А В Соболев,
А В Соболев,
Е. В. Фролова,
Е. В. Фролова,
О В Аак,
Аак О В,
Ekaterina Burygina,
Ekaterina Burygina,
Н Н Климко,
Н Н Климко
Publication year - 2015
Publication title -
rossijskij allergologičeskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2686-682X
pISSN - 1810-8830
DOI - 10.36691/rja455
Subject(s) - allergic bronchopulmonary aspergillosis , bronchiectasis , medicine , asthma , cystic fibrosis , aspergillosis , disease , intensive care medicine , lung disease , immunology , lung , pediatrics , immunoglobulin e , antibody
Allergic bronchopulmonary aspergillosis (ABPA) is a caused by hypersensitivity to Aspergillus spp. antigens, is the lung disease, which occurs in patients with asthma or cystic fibrosis and is characterized by poor control of background disease and development of respiratory failure. According to experts opinion the number of patients with ABPA is about four million people in the world and 175 000 persons in Russian Federation. The clinical course improvement, prevention of progression and prophylaxis of bronchiectasis depend on timely and correct diagnosis of the disease. International Society of Human and Animal Mycology (ISHAM) formed a working group «ABPA in patients with asthma» for worldwide collaboration with physicians and researchers. The working group proposed new diagnostic criteria. This report presents a clinical case of ABPA in asthmatic patient. The diagnosis is established according criteria proposed by R. Agarwal et al., 2013.